# Belden Inc.: overview

BDC · NYSE · CIK 913142 · [Materials](/sectors/materials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/bdc.md) · [Financials](/companies/bdc/financials.md) · [Filings](/companies/bdc/filings.md) · [Insiders](/companies/bdc/insiders.md)

Latest reported revenue: [$966.0m](/filings/0000913142-26-000042.md) for Q3 FY2026, three months to 2026-09-27, from the 10-Q filed Oct 29, 2026 (XBRL us-gaap:Revenues, accession 0000913142-26-000042).

## Last eight quarters

| Line item | Unit | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-30) | Q2 FY2025 (2025-06-29) | Q3 FY2025 (2025-09-28) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-29) | Q2 FY2026 (2026-06-28) | Q3 FY2026 (2026-09-27) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [666 d](/filings/0000913142-26-000009.md) | [625](/filings/0000913142-26-000023.md) | [672](/filings/0000913142-26-000034.md) | [698](/filings/0000913142-26-000042.md) | [720 d](/filings/0000913142-26-000009.md) | [696](/filings/0000913142-26-000023.md) | [750](/filings/0000913142-26-000034.md) | [966](/filings/0000913142-26-000042.md) |
| Gross margin | % | [37.5% d](/filings/0000913142-26-000009.md) | [39.3%](/filings/0000913142-26-000023.md) | [38.5%](/filings/0000913142-26-000034.md) | [37.7%](/filings/0000913142-26-000042.md) | [36.6% d](/filings/0000913142-26-000009.md) | [37.1%](/filings/0000913142-26-000023.md) | [39.1%](/filings/0000913142-26-000034.md) | [35.1%](/filings/0000913142-26-000042.md) |
| Operating margin | % | [10.4% d](/filings/0000913142-26-000009.md) | [11.6%](/filings/0000913142-26-000023.md) | [11.8%](/filings/0000913142-26-000034.md) | [10.9%](/filings/0000913142-26-000042.md) | [12.2% d](/filings/0000913142-26-000009.md) | [11.2%](/filings/0000913142-26-000023.md) | [13.2%](/filings/0000913142-26-000034.md) | [1.7%](/filings/0000913142-26-000042.md) |
| Net margin | % | [8.8% d](/filings/0000913142-26-000009.md) | [8.3%](/filings/0000913142-26-000042.md) | [9.1%](/filings/0000913142-26-000042.md) | [8.1%](/filings/0000913142-26-000042.md) | [9.4% d](/filings/0000913142-26-000009.md) | [7.3%](/filings/0000913142-26-000042.md) | [9.1%](/filings/0000913142-26-000042.md) | [(1.2%)](/filings/0000913142-26-000042.md) |
| Diluted EPS | $ per share | not reported | [1.27](/filings/0000913142-26-000023.md) | [1.53](/filings/0000913142-26-000034.md) | [1.41](/filings/0000913142-26-000042.md) | not reported | [1.30](/filings/0000913142-26-000023.md) | [1.74](/filings/0000913142-26-000034.md) | [(0.29)](/filings/0000913142-26-000042.md) |
| Free cash flow | $m | [116 d](/filings/0000913142-26-000009.md) | [(24.8)](/filings/0000913142-26-000023.md) | [56.9 d](/filings/0000913142-26-000034.md) | [65.3 d](/filings/0000913142-26-000042.md) | [121 d](/filings/0000913142-26-000009.md) | [(63.1)](/filings/0000913142-26-000023.md) | [88.6 d](/filings/0000913142-26-000034.md) | [81.8 d](/filings/0000913142-26-000042.md) |

- Revenue. XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 12-month figure less the 9-month figure; 6-month figure less the 3-month figure; 9-month figure less the 6-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [2,301](/filings/0000913142-24-000007.md) | [2,606](/filings/0000913142-25-000005.md) | [2,512](/filings/0000913142-26-000009.md) | [2,461](/filings/0000913142-26-000009.md) | [2,715](/filings/0000913142-26-000009.md) |
| Gross margin | % | [33.5%](/filings/0000913142-24-000007.md) | [35.2%](/filings/0000913142-25-000005.md) | [38.0%](/filings/0000913142-26-000009.md) | [37.5%](/filings/0000913142-26-000009.md) | [38.0%](/filings/0000913142-26-000009.md) |
| Operating margin | % | [11.5%](/filings/0000913142-24-000007.md) | [13.9%](/filings/0000913142-25-000005.md) | [12.6%](/filings/0000913142-26-000009.md) | [10.8%](/filings/0000913142-26-000009.md) | [11.6%](/filings/0000913142-26-000009.md) |
| Net margin | % | [2.8%](/filings/0000913142-24-000007.md) | [9.8%](/filings/0000913142-25-000005.md) | [9.7%](/filings/0000913142-26-000009.md) | [8.1%](/filings/0000913142-26-000009.md) | [8.7%](/filings/0000913142-26-000009.md) |
| Diluted EPS | $ per share | [1.41](/filings/0000913142-24-000007.md) | [5.72](/filings/0000913142-25-000005.md) | [5.66](/filings/0000913142-26-000009.md) | [4.80](/filings/0000913142-26-000009.md) | [5.91](/filings/0000913142-26-000009.md) |
| Free cash flow | $m | [181](/filings/0000913142-24-000007.md) | [176](/filings/0000913142-25-000005.md) | [203](/filings/0000913142-26-000009.md) | [223](/filings/0000913142-26-000009.md) | [219](/filings/0000913142-26-000009.md) |

- Revenue. XBRL Revenue: us-gaap:Revenues.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:Revenues.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/bdc/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $616.5m | 5,141,658 |  | Added +223,785 |
| [FMR LLC](/funds/315066.md) | 2026-06-30 | $485.2m | 4,046,029 |  | Added +122,035 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $330.8m | 2,758,725 |  | Added +56,396 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $210.3m | 1,753,428 |  | Added +11,065 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $180.5m | 1,504,721 |  | Added +23,029 |
| [WELLINGTON MANAGEMENT GROUP LLP](/funds/902219.md) | 2026-06-30 | $171.6m | 1,431,187 |  | Reduced −157,218 |
| [FULLER & THALER ASSET MANAGEMENT, INC.](/funds/1082327.md) | 2026-06-30 | $141.0m | 1,176,261 |  | Added +125,934 |
| [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $135.2m | 1,127,823 |  | Added +94,974 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $127.9m | 1,066,428 |  | Added +57,775 |
| [Invesco Ltd.](/funds/914208.md) | 2026-06-30 | $101.7m | 847,997 |  | Added +106,172 |

## Recent filings

[All 1,457 filings](/companies/bdc/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-29 | 14:44 ET | [10-Q](/filings/0000913142-26-000042.md) | Quarterly report, period 2026-09-27 | 0000913142-26-000042 |
| 2026-10-29 | 07:54 ET | [8-K](/filings/0000913142-26-000039.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000913142-26-000039 |
| 2026-09-11 | 17:05 ET | [8-K/A](/filings/0000913142-26-000037.md) | 9.01 Financial statements and exhibits | 0000913142-26-000037 |
| 2026-07-30 | 14:53 ET | [10-Q](/filings/0000913142-26-000034.md) | Quarterly report, period 2026-06-28 | 0000913142-26-000034 |
| 2026-07-30 | 08:00 ET | [8-K](/filings/0000913142-26-000031.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000913142-26-000031 |
| 2026-07-01 | 08:34 ET | [8-K](/filings/0000913142-26-000029.md) | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0000913142-26-000029 |
| 2026-05-26 | 15:52 ET | [8-K](/filings/0000913142-26-000025.md) | 5.07 Shareholder vote results | 0000913142-26-000025 |
| 2026-04-30 | 13:52 ET | [10-Q](/filings/0000913142-26-000023.md) | Quarterly report, period 2026-03-29 | 0000913142-26-000023 |
| 2026-04-30 | 08:00 ET | [8-K](/filings/0000913142-26-000021.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000913142-26-000021 |
| 2026-04-30 | 07:55 ET | [8-K](/filings/0000913142-26-000020.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0000913142-26-000020 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0000913142-26-000009.md), filed Feb 17, 2026.

## Forecast league

Q3 FY2026, the quarter ended 2026-09-28, has been scored from the reported figures. [See the target](/leagues/2026q3/targets/36a7a632-0b7f-463e-a0ec-30a247654557)

## About the filer

- CIK: 913142
- Tickers: BDC
- Exchange: NYSE
- SIC code: 3357 Drawing & Insulating of  Nonferrous Wire
- State of incorporation: DE
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 29, 2026, 14:50 ET. No prices; not investment advice.
